Ovarian cancer is a silent disease with a poor prognosis that urgently requires new therapeutic strategies. In low-grade ovarian tumours, mutations in the MAP3K BRAF gene constitutively activate the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback